Post-Polycythemia Vera Myelofibrosis (PPV-MF)
Showing 26 - 50 of >10,000
Primary Myelofibrosis, Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide (RO7490677,
MPN (Myeloproliferative Tumors) Trial in United States (Ruxolitinib)
Completed
- MPN (Myeloproliferative Neoplasms)
-
Birmingham, Alabama
- +37 more
Jan 17, 2020
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Recruiting
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Physician's Choice medications
-
Birmingham, Alabama
- +151 more
Aug 22, 2022
Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)
Terminated
- Primary Myelofibrosis
- +2 more
-
Scottsdale, Arizona
- +8 more
Jul 9, 2021
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide
Completed
- Primary Myelofibrosis
- +4 more
-
Scottsdale, Arizona
- +21 more
Jan 18, 2021
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide
Completed
- Primary Myelofibrosis
- +2 more
-
Phoenix, Arizona
- +61 more
May 5, 2022
Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV) Myelofibrosis, Postessential Thrombocythemia (Post-ET)
Completed
- Primary Myelofibrosis (PMF)
- +2 more
-
Phoenix, Arizona
- +12 more
Jan 12, 2021
Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)
Active, not recruiting
- Myelofibrosis
- +2 more
-
New Orleans, Louisiana
- +20 more
Aug 25, 2022
Myelofibrosis, Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)
Recruiting
- Myelofibrosis
- +3 more
- Jaktinib hydrochloride tablets
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Medical School of Zhejiang Univ
Jun 11, 2021
Chronic Phase Myelofibrosis, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Boston, Bronx, New
Completed
- Chronic Phase Myelofibrosis
- +3 more
-
Boston, Massachusetts
- +2 more
May 27, 2021
Myelofibrosis Trial in Stanford, Ann Arbor (Idelalisib, Ruxolitinib)
Terminated
- Myelofibrosis
-
Stanford, California
- +1 more
Aug 31, 2020
Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary
Recruiting
- Myelofibrosis Transformation in Essential Thrombocythemia
- +2 more
- Elotuzumab
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Feb 17, 2021
Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in
Recruiting
- Primary Myelofibrosis (PMF)
- +2 more
- KRT-232
- Best Available Therapy (BAT)
-
Birmingham, Alabama
- +155 more
Aug 12, 2022
Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) Trial
Completed
- Primary Myelofibrosis (PMF)
- +2 more
- Momelotinib
- Best Available Therapy (BAT)
-
Los Angeles, California
- +47 more
Apr 1, 2020
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Active, not recruiting
- Primary Myelofibrosis
- +2 more
- Momelotinib
- +3 more
-
Phoenix, Arizona
- +166 more
Jan 27, 2022